Importantly, they found that human melanoma tumors responding to anti‐CTLA4 and anti‐PD1 had upregulation of 15/16 inflammasome‐related genes that was not detected in melanoma that did not respond to ICB (Segovia et al., 2019). Here, CTLA4 is linked to melanoma.